Elite Pharmaceuticals, Inc.: 10-Q filed 2014-02-14

Name: Elite Pharmaceuticals, Inc.: 10-Q filed 2014-02-14
Creator: Elite Pharmaceuticals, Inc.

What Elite Pharmaceuticals, Inc. reported in its quarterly report filed 2014-02-14 (fiscal Q3 2013): 39 published measures, 114 facts as tagged in accession 0001144204-14-008935.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-02-14
Fiscal period: fiscal Q3 2013
Accession: 0001144204-14-008935 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Elite Pharmaceuticals, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-12-31	18,276,723	USD
At 2013-03-31	11,125,133	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-12-31	23,204,149	USD
At 2013-03-31	19,798,518	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-12-31	-4,927,426	USD
At 2013-03-31	-8,673,385	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-12-31	1,080,792	USD
At 2013-03-31	369,023	USD
At 2012-12-31	65,655	USD
At 2012-03-31	668,407	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	-1,061,851	USD	92
2013-04-01 to 2013-12-31	-9,777,695	USD	275
2012-10-01 to 2012-12-31	9,363,166	USD	92
2012-04-01 to 2012-12-31	-109,023	USD	275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-04-01 to 2013-12-31	-2,741,608	USD	275
2012-04-01 to 2012-12-31	-1,466,724	USD	275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-04-01 to 2013-12-31	3,946,746	USD	275
2012-04-01 to 2012-12-31	1,110,027	USD	275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2013-04-01 to 2013-12-31	-493,369	USD	275
2012-04-01 to 2012-12-31	-246,055	USD	275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-12-31	-138,209,070	USD
At 2013-03-31	-128,431,375	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	508,638,816	shares	92
2013-04-01 to 2013-12-31	439,720,987	shares	275
2012-10-01 to 2012-12-31	350,220,224	shares	92
2012-04-01 to 2012-12-31	345,384,514	shares	275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	508,638,816	shares	92
2013-04-01 to 2013-12-31	439,720,987	shares	275
2012-10-01 to 2012-12-31	486,207,413	shares	92
2012-04-01 to 2012-12-31	345,384,514	shares	275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	0	USD/shares	92
2013-04-01 to 2013-12-31	-0.02	USD/shares	275
2012-10-01 to 2012-12-31	0.03	USD/shares	92
2012-04-01 to 2012-12-31	0	USD/shares	275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	0	USD/shares	92
2013-04-01 to 2013-12-31	-0.02	USD/shares	275
2012-10-01 to 2012-12-31	0	USD/shares	92
2012-04-01 to 2012-12-31	0	USD/shares	275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-12-31	4,116,597	USD
At 2013-03-31	4,028,943	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	-1,237,152	USD	92
2013-04-01 to 2013-12-31	-2,899,322	USD	275
2012-10-01 to 2012-12-31	-274,210	USD	92
2012-04-01 to 2012-12-31	-1,275,243	USD	275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-12-31	3,917,786	USD
At 2013-03-31	2,543,374	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	359,130	USD	92
2013-04-01 to 2013-12-31	689,852	USD	275
2012-10-01 to 2012-12-31	63,924	USD	92
2012-04-01 to 2012-12-31	183,709	USD	275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-12-31	12,505,260	USD
At 2013-03-31	5,357,255	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2013-12-31	1,024,284	USD
At 2013-03-31	665,154	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	1,935,816	USD	92
2013-04-01 to 2013-12-31	4,282,925	USD	275
2012-10-01 to 2012-12-31	675,100	USD	92
2012-04-01 to 2012-12-31	1,955,210	USD	275

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2013-12-31	1,531,645	USD
At 2013-03-31	1,358,146	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	698,664	USD	92
2013-04-01 to 2013-12-31	1,383,603	USD	275
2012-10-01 to 2012-12-31	400,890	USD	92
2012-04-01 to 2012-12-31	679,967	USD	275

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	994,582	USD	92
2013-04-01 to 2013-12-31	2,190,229	USD	275
2012-10-01 to 2012-12-31	266,792	USD	92
2012-04-01 to 2012-12-31	1,200,787	USD	275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	1,290,858	USD	92
2013-04-01 to 2013-12-31	2,715,126	USD	275
2012-10-01 to 2012-12-31	238,268	USD	92
2012-04-01 to 2012-12-31	663,625	USD	275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-12-31	513,117,800	shares
At 2013-03-31	374,393,959	shares

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2013-12-31	5,391,686	USD
At 2013-03-31	5,068,522	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2013-12-31	6,314,621	USD
At 2013-03-31	694,426	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2013-12-31	98,340	USD
At 2013-03-31	91,571	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2013-12-31	281,065	USD
At 2013-03-31	151,051	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	-1,061,851	USD	92
2013-04-01 to 2013-12-31	-9,775,426	USD	275
2012-10-01 to 2012-12-31	9,363,166	USD	92
2012-04-01 to 2012-12-31	-105,000	USD	275

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	-1,061,851	USD	92
2013-04-01 to 2013-12-31	-9,777,695	USD	275
2012-10-01 to 2012-12-31	9,363,166	USD	92
2012-04-01 to 2012-12-31	-109,023	USD	275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	494,469	USD	92
2013-04-01 to 2013-12-31	1,143,487	USD	275
2012-10-01 to 2012-12-31	380,976	USD	92
2012-04-01 to 2012-12-31	1,147,112	USD	275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2013-04-01 to 2013-12-31	334,277	USD	275
2012-04-01 to 2012-12-31	330,543	USD	275

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Unit	Days
2013-10-01 to 2013-12-31	USD	92
2013-04-01 to 2013-12-31	USD	275
2013-07-01 to 2013-09-30	USD	92
2013-04-01 to 2013-06-30	USD	91

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	0	USD	92
2013-04-01 to 2013-12-31	19,831	USD	275
2012-10-01 to 2012-12-31	0	USD	92
2012-04-01 to 2012-12-31	0	USD	275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2013-10-01 to 2013-12-31	175,301	USD	92
2013-04-01 to 2013-12-31	-6,876,104	USD	275
2012-10-01 to 2012-12-31	9,637,376	USD	92
2012-04-01 to 2012-12-31	1,170,243	USD	275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2013-04-01 to 2013-12-31	3,510,000	USD	275
2012-04-01 to 2012-12-31	0	USD	275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-04-01 to 2013-12-31	359,130	USD	275
2012-04-01 to 2012-12-31	129,539	USD	275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-04-01 to 2013-12-31	173,499	USD	275
2012-04-01 to 2012-12-31	679,549	USD	275

Inspect the source

Entity: Elite Pharmaceuticals, Inc. / CIK 0001053369
Captured: 2026-09-20T05:17:33.154Z
SEC response SHA-256: b91e0331a01f96870ee44e841f605bd504e1bc784022b77f374cfe93dc363314

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001053369.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))